Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112388298 | 11238829 | 8 | F | 20131105 | 20160802 | 20150706 | 20160805 | EXP | CA-ROCHE-1603761 | ROCHE | 57.62 | YR | M | Y | 0.00000 | 20160805 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112388298 | 11238829 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 375 MG, BIW | U | S00062,S0002F | 103976 | 375 | MG | SOLUTION FOR INJECTION | QOW | ||||
| 112388298 | 11238829 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 375 MG, BIW | U | S00062,S0002F | 103976 | 375 | MG | SOLUTION FOR INJECTION | QOW | ||||
| 112388298 | 11238829 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 9 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 10 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 11 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 12 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 13 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 14 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 15 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 16 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S00062,S0002F | 103976 | SOLUTION FOR INJECTION | |||||||
| 112388298 | 11238829 | 17 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 112388298 | 11238829 | 18 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 112388298 | 11238829 | 19 | C | ZENHALE | FORMOTEROL FUMARATEMOMETASONE FUROATE | 1 | 0 | ||||||||||||
| 112388298 | 11238829 | 20 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 112388298 | 11238829 | 21 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 112388298 | 11238829 | 22 | C | NORVASC | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 112388298 | 11238829 | 23 | C | ATIVAN | LORAZEPAM | 1 | 0 | ||||||||||||
| 112388298 | 11238829 | 24 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112388298 | 11238829 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112388298 | 11238829 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112388298 | 11238829 | Blood pressure increased | |
| 112388298 | 11238829 | Oxygen saturation decreased | |
| 112388298 | 11238829 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112388298 | 11238829 | 1 | 20130716 | 0 | ||
| 112388298 | 11238829 | 2 | 20131105 | 0 | ||
| 112388298 | 11238829 | 3 | 20131203 | 0 | ||
| 112388298 | 11238829 | 4 | 20141014 | 0 | ||
| 112388298 | 11238829 | 5 | 20141028 | 0 | ||
| 112388298 | 11238829 | 6 | 20141125 | 0 | ||
| 112388298 | 11238829 | 7 | 20150120 | 0 | ||
| 112388298 | 11238829 | 8 | 20150623 | 0 | ||
| 112388298 | 11238829 | 9 | 20150915 | 0 | ||
| 112388298 | 11238829 | 10 | 20151027 | 0 | ||
| 112388298 | 11238829 | 11 | 20151124 | 0 | ||
| 112388298 | 11238829 | 12 | 20160105 | 0 | ||
| 112388298 | 11238829 | 13 | 20160119 | 0 | ||
| 112388298 | 11238829 | 14 | 20160301 | 0 | ||
| 112388298 | 11238829 | 15 | 20160719 | 0 | ||
| 112388298 | 11238829 | 16 | 20160802 | 0 |